Industry: Service & Software
Published Date: 2026-01-04
Pages: 101 Pages
Report ld: 5536089
Request Sample
Customized Report
Interleukin Market Size(US$)

CAGR 2026-2032
9.9%
Market Size,2032
USD 98
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Interleukin market was valued at US$ 51.2 million in 2025 and is anticipated to reach US$ 98 million by 2032, at a CAGR of 9.9% from 2026 to 2032.
Interleukins are a group of cytokines (proteins) that play a crucial role in cell signaling and immune responses. They are produced by various cells of the immune system, such as leukocytes, macrophages, and lymphocytes, and they act as messengers between cells to regulate inflammation, immune responses, and hematopoiesis (the formation of blood cells).
Global key players of Interleukin include Bio-Techne, Cytiva, Lonza, etc. The top three players hold a share over 43%. North America is the largest market, with a share about 52%, followed by Europe and Asia-Pacific, with share 28% and 17%, separately. In terms of product type, Pharmaceutical Grade is the largest segment, occupied for a share of 73%. In terms of application, Medical is the largest, which has a share about 73 percent.
This report delivers a comprehensive overview of the global Interleukin market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Interleukin. The Interleukin market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Interleukin market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Interleukin manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Interleukin companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Interleukin Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Pharmaceutical Grade
1.2.3 Other
1.3 Market by Application
1.3.1 Global Interleukin Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Medical
1.3.3 Culture Medium Supplement
1.3.4 Scientific Research
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Interleukin Market Perspective (2021–2032)
2.2 Global Interleukin Growth Trends by Region
2.2.1 Global Interleukin Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Interleukin Historic Market Size by Region (2021–2026)
2.2.3 Interleukin Forecasted Market Size by Region (2027–2032)
2.3 Interleukin Market Dynamics
2.3.1 Interleukin Industry Trends
2.3.2 Interleukin Market Drivers
2.3.3 Interleukin Market Challenges
2.3.4 Interleukin Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Interleukin Players by Revenue
3.1.1 Global Top Interleukin Players by Revenue (2021–2026)
3.1.2 Global Interleukin Revenue Market Share by Players (2021–2026)
3.2 Global Top Interleukin Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Interleukin Revenue
3.4 Global Interleukin Market Concentration Ratio
3.4.1 Global Interleukin Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Interleukin Revenue in 2025
3.5 Global Key Players of Interleukin Head Offices and Areas Served
3.6 Global Key Players of Interleukin, Products and Applications
3.7 Global Key Players of Interleukin, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Interleukin Breakdown Data by Type
4.1 Global Interleukin Historic Market Size by Type (2021–2026)
4.2 Global Interleukin Forecasted Market Size by Type (2027–2032)
5 Interleukin Breakdown Data by Application
5.1 Global Interleukin Historic Market Size by Application (2021–2026)
5.2 Global Interleukin Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Interleukin Market Size (2021–2032)
6.2 North America Interleukin Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Interleukin Market Size by Country (2021–2026)
6.4 North America Interleukin Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Interleukin Market Size (2021–2032)
7.2 Europe Interleukin Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Interleukin Market Size by Country (2021–2026)
7.4 Europe Interleukin Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Interleukin Market Size (2021–2032)
8.2 Asia-Pacific Interleukin Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Interleukin Market Size by Region (2021–2026)
8.4 Asia-Pacific Interleukin Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Interleukin Market Size (2021–2032)
9.2 Latin America Interleukin Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Interleukin Market Size by Country (2021–2026)
9.4 Latin America Interleukin Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Interleukin Market Size (2021–2032)
10.2 Middle East & Africa Interleukin Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Interleukin Market Size by Country (2021–2026)
10.4 Middle East & Africa Interleukin Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Cytiva
11.1.1 Cytiva Company Details
11.1.2 Cytiva Business Overview
11.1.3 Cytiva Interleukin Introduction
11.1.4 Cytiva Revenue in Interleukin Business (2021–2026)
11.1.5 Cytiva Recent Development
11.2 Bio-Techne
11.2.1 Bio-Techne Company Details
11.2.2 Bio-Techne Business Overview
11.2.3 Bio-Techne Interleukin Introduction
11.2.4 Bio-Techne Revenue in Interleukin Business (2021–2026)
11.2.5 Bio-Techne Recent Development
11.3 Lonza
11.3.1 Lonza Company Details
11.3.2 Lonza Business Overview
11.3.3 Lonza Interleukin Introduction
11.3.4 Lonza Revenue in Interleukin Business (2021–2026)
11.3.5 Lonza Recent Development
11.4 Sartorius CellGenix
11.4.1 Sartorius CellGenix Company Details
11.4.2 Sartorius CellGenix Business Overview
11.4.3 Sartorius CellGenix Interleukin Introduction
11.4.4 Sartorius CellGenix Revenue in Interleukin Business (2021–2026)
11.4.5 Sartorius CellGenix Recent Development
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Company Details
11.5.2 Thermo Fisher Scientific Business Overview
11.5.3 Thermo Fisher Scientific Interleukin Introduction
11.5.4 Thermo Fisher Scientific Revenue in Interleukin Business (2021–2026)
11.5.5 Thermo Fisher Scientific Recent Development
11.6 Miltenyi Biotec
11.6.1 Miltenyi Biotec Company Details
11.6.2 Miltenyi Biotec Business Overview
11.6.3 Miltenyi Biotec Interleukin Introduction
11.6.4 Miltenyi Biotec Revenue in Interleukin Business (2021–2026)
11.6.5 Miltenyi Biotec Recent Development
11.7 Akron Biotech
11.7.1 Akron Biotech Company Details
11.7.2 Akron Biotech Business Overview
11.7.3 Akron Biotech Interleukin Introduction
11.7.4 Akron Biotech Revenue in Interleukin Business (2021–2026)
11.7.5 Akron Biotech Recent Development
11.8 Sino Biological
11.8.1 Sino Biological Company Details
11.8.2 Sino Biological Business Overview
11.8.3 Sino Biological Interleukin Introduction
11.8.4 Sino Biological Revenue in Interleukin Business (2021–2026)
11.8.5 Sino Biological Recent Development
11.9 Creative Bioarray
11.9.1 Creative Bioarray Company Details
11.9.2 Creative Bioarray Business Overview
11.9.3 Creative Bioarray Interleukin Introduction
11.9.4 Creative Bioarray Revenue in Interleukin Business (2021–2026)
11.9.5 Creative Bioarray Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Interleukin market size was US$ 51.2 million in 2025 and is forecast to reach a readjusted size of US$ 98 million by 2032 with a CAGR of 9.9% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 78
USD 4250.00
(Single User License)
The global market for Interleukin was estimated to be worth US$ 51.2 million in 2025 and is projected to reach US$ 98 million, growing at a CAGR of 9.9% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 84
USD 3950.00
(Single User License)
The global Interleukin market is projected to grow from US$ 47 million in 2024 to US$ 90.1 million by 2031, at a CAGR of 9.9% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-09-11
Pages: 116
USD 4900.00
(Single User License)
In 2024, the global market size of Interleukin was estimated to be worth US$ 47 million and is forecast to reach approximately US$ 90.1 million by 2031 with a CAGR of 9.9% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 119
USD 5900.00
(Single User License)
The global Interleukin market size was US$ 47 million in 2024 and is forecast to a readjusted size of US$ 90.1 million by 2031 with a CAGR of 9.9% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 79
USD 4250.00
(Single User License)
The global market for Interleukin was estimated to be worth US$ 47 million in 2024 and is forecast to a readjusted size of US$ 90.1 million by 2031 with a CAGR of 9.9% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 82
USD 3950.00
(Single User License)
The global market for Interleukin was valued at US$ 47 million in the year 2024 and is projected to reach a revised size of US$ 90.1 million by 2031, growing at a CAGR of 9.9% during the forecast period.
Published Date: 2025-01-16
Pages: 79
USD 2900.00
(Single User License)
Interleukins are a group of cytokines (proteins) that play a crucial role in cell signaling and immune responses. They are produced by various cells of the immune system, such as leukocytes, macrophages, and lymphocytes, and they act as messengers between cells to regulate inflammation, immune responses, and hematopoiesis (the formation of blood cells).
Published Date: 2024-04-28
Pages: 92
USD 4350.00
(Single User License)
Interleukins are a group of cytokines (proteins) that play a crucial role in cell signaling and immune responses. They are produced by various cells of the immune system, such as leukocytes, macrophages, and lymphocytes, and they act as messengers between cells to regulate inflammation, immune responses, and hematopoiesis (the formation of blood cells).
Published Date: 2024-04-28
Pages: 97
USD 3950.00
(Single User License)
Interleukins are a group of cytokines (proteins) that play a crucial role in cell signaling and immune responses. They are produced by various cells of the immune system, such as leukocytes, macrophages, and lymphocytes, and they act as messengers between cells to regulate inflammation, immune responses, and hematopoiesis (the formation of blood cells).
Published Date: 2024-04-28
Pages: 127
USD 4900.00
(Single User License)
The global Interleukin market size was US$ 51.2 million in 2025 and is forecast to reach a readjusted size of US$ 98 million by 2032 with a CAGR of 9.9% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 78
The global market for Interleukin was estimated to be worth US$ 51.2 million in 2025 and is projected to reach US$ 98 million, growing at a CAGR of 9.9% from 2026 to 2032.
Published: 2026-01-04
Pages: 84
The global Interleukin market is projected to grow from US$ 47 million in 2024 to US$ 90.1 million by 2031, at a CAGR of 9.9% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-09-11
Pages: 116
In 2024, the global market size of Interleukin was estimated to be worth US$ 47 million and is forecast to reach approximately US$ 90.1 million by 2031 with a CAGR of 9.9% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 119
The global Interleukin market size was US$ 47 million in 2024 and is forecast to a readjusted size of US$ 90.1 million by 2031 with a CAGR of 9.9% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 79
The global market for Interleukin was estimated to be worth US$ 47 million in 2024 and is forecast to a readjusted size of US$ 90.1 million by 2031 with a CAGR of 9.9% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 82
The global market for Interleukin was valued at US$ 47 million in the year 2024 and is projected to reach a revised size of US$ 90.1 million by 2031, growing at a CAGR of 9.9% during the forecast period.
Published: 2025-01-16
Pages: 79
Interleukins are a group of cytokines (proteins) that play a crucial role in cell signaling and immune responses. They are produced by various cells of the immune system, such as leukocytes, macrophages, and lymphocytes, and they act as messengers between cells to regulate inflammation, immune responses, and hematopoiesis (the formation of blood cells).
Published: 2024-04-28
Pages: 92
Interleukins are a group of cytokines (proteins) that play a crucial role in cell signaling and immune responses. They are produced by various cells of the immune system, such as leukocytes, macrophages, and lymphocytes, and they act as messengers between cells to regulate inflammation, immune responses, and hematopoiesis (the formation of blood cells).
Published: 2024-04-28
Pages: 97
Interleukins are a group of cytokines (proteins) that play a crucial role in cell signaling and immune responses. They are produced by various cells of the immune system, such as leukocytes, macrophages, and lymphocytes, and they act as messengers between cells to regulate inflammation, immune responses, and hematopoiesis (the formation of blood cells).
Published: 2024-04-28
Pages: 127
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now